Compared to MCF-7, both the upregulation of CD44+CD24–/low subpopulation ratio and IC50 of adriamycin indicated that breast cancer stem cells displaying chemoresistance would also play an important role in tamoxifen resistance. The gene discussed is CD24; the disease is breast carcinoma.